Qlaris Bio
MA - DedhamBiotechnology
Focus: Qlaris Bio is a Massachusetts-based biotechnology company focused on ocular small molecules targeting glaucoma, diabetic retinopathy, and rare vascular conditions. The company operates as a pre-revenue or early-stage biotech with a concentrated pipeline in ophthalmology and oncology.
Profile data last refreshed 2d ago · AI intelligence enriched 1w ago
Open Jobs
0
About Qlaris Bio
AI assessmentNot HiringNo open roles listed right now. Follow Qlaris Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
QLS-101 ophthalmic solution, 2.0 %
Sturge-Weber SyndromeQLS-101ophthalmic solution 1%
Sturge-Weber Syndrome (SWS)Help build intelligence for Qlaris Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.